How Much Did Evidium Raise in Its Series A?

Evidium raised $22 million in a Series A round announced in November 2025. The San Francisco healthcare AI company was led in the round by Health2047 and WGG Partners.

What does Evidium do?

Evidium builds computational medical knowledge software that turns medical evidence into traceable insights on patient journeys, costs and outcomes. Its products include clinician quality insights and probabilistic forecasting for insurers.

Who invested in the round?

Health2047, the venture studio of the American Medical Association, and WGG Partners co-led it. x.AI, Perplexity, Innovaccer, Interwoven Ventures and Mindset Ventures also took part.

What is the money for, and who founded Evidium?

The funds will go to product development, deeper clinical modeling and commercial growth. Carl Bate is the founder and CEO.

Quick answers

How much did Evidium raise? $22 million.

Who led the round? Health2047 and WGG Partners.

Who is the CEO? Carl Bate.